Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Uterine Neoplasms × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tuberous Sclerosis 2 Autistic Disorder 2 Uterine Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Intellectual Disability 1 Hamartoma Syndrome, Multiple 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Gallbladder Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Letrozole 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03285802 2020-02-05

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Greater Baltimore Medical Center

Phase 2/3 Completed

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡